Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s Jim Cramer, and
Tag: RayzeBio Inc
Cramer names biopharma companies as industry mergers start to accrue
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some
INTC, NIO, FDX, MANU and more
Check out the companies making headlines in midday trading. Intel — The semiconductor stock added 5.2% after Israel’s government announced a $3.2
No More Posts Available.
No more pages to load.